Trial Profile
Ezetimibe/Simvastatin and Rosuvastatin for Oxidative Stress and Mitochondrial Function in Diabetic Polyneuropathy: a Randomized, Double Blinded, Placebo Controlled Clinical Trial
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Ezetimibe/simvastatin (Primary) ; Rosuvastatin (Primary)
- Indications Diabetic neuropathies
- Focus Pharmacodynamics
- 05 Jul 2014 New trial record